ANGELE WOOD: Open Payments
NPI 1518417906 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $189 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Amgen Inc. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Antares Pharma, Inc. | 2 | $30 |
| Viatris Specialty LLC | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
Products named: QULIPTA, XIFAXAN, OTEZLA, XYOSTED, YUPELRI, VRAYLAR, INSPIRE, BREZTRI.
Industry payments across TX — which companies pay providers there.
